We then assigned pathogenicity scores to each of the alterations, and noted that many of the alterations (e.g., CDKN2A, FAT1, PIK3CA and/or TP53) were highly likely to have a pathogenic role in the tumor (Table S4). The gene discussed is CDKN2A; the disease is neoplasm.